The total number of shares to be listed and traded is 169,360,000 shares, and the listing and trading date is October 28, 2026.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Listing and Trading of Certain Restricted Shares from the Initial Public Offering
Filed with SSE · Stock code 688062 · · 5 pages · Chinese
Summary by 6ix AI
Mabwell (Shanghai) Bioscience Co., Ltd. has announced the listing and trading of certain restricted shares from its initial public offering. The total number of restricted shares being listed is significant, representing a substantial portion of the company's A-share capital. The shares will become tradable on a specified date, following the expiration of their lock-up period. The announcement includes commitments from shareholders regarding the sale of their shares post-lock-up.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Mabwell (Shanghai) Bioscience Co., Ltd. on 6ix
Story so far
Earlier from Mabwell (Shanghai) Bioscience
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on External Investment and Introduction of Investors to Lianwei Chuangyuan
- Announcement on Resolutions of the 3rd Meeting of the 3rd Board of Directors
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
- ERS 2026 | Mabwell Presents Phase Ib/IIa Clinical Results of Anti-ST2 Monoclonal Antibody 9MW1911 in COPD Patients
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
Later from Mabwell (Shanghai) Bioscience
All Mabwell (Shanghai) Bioscience news releasesFollow Mabwell (Shanghai) Bioscience into a list and get an email when it puts out news.
Follow Mabwell (Shanghai) Bioscience